State of Alaska Department of Revenue Cuts Stake in Addus HomeCare Co. (NASDAQ:ADUS)

State of Alaska Department of Revenue cut its holdings in shares of Addus HomeCare Co. (NASDAQ:ADUSFree Report) by 2.3% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 9,750 shares of the company’s stock after selling 226 shares during the quarter. State of Alaska Department of Revenue owned 0.06% of Addus HomeCare worth $1,007,000 at the end of the most recent quarter.

Other hedge funds have also recently made changes to their positions in the company. Exchange Traded Concepts LLC raised its position in Addus HomeCare by 0.8% in the 4th quarter. Exchange Traded Concepts LLC now owns 14,310 shares of the company’s stock worth $1,329,000 after purchasing an additional 113 shares during the period. GAMMA Investing LLC lifted its stake in shares of Addus HomeCare by 40.8% in the 1st quarter. GAMMA Investing LLC now owns 556 shares of the company’s stock valued at $57,000 after acquiring an additional 161 shares during the last quarter. Principal Securities Inc. bought a new stake in shares of Addus HomeCare in the 4th quarter valued at about $26,000. Tudor Investment Corp Et Al boosted its holdings in Addus HomeCare by 0.7% during the 3rd quarter. Tudor Investment Corp Et Al now owns 40,784 shares of the company’s stock valued at $3,474,000 after acquiring an additional 295 shares during the period. Finally, Sheets Smith Wealth Management grew its position in Addus HomeCare by 4.6% during the 4th quarter. Sheets Smith Wealth Management now owns 7,207 shares of the company’s stock worth $669,000 after acquiring an additional 315 shares during the last quarter. 95.35% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other news, EVP Roberton James Stevenson sold 217 shares of the business’s stock in a transaction that occurred on Monday, June 17th. The stock was sold at an average price of $116.13, for a total value of $25,200.21. Following the sale, the executive vice president now directly owns 10,217 shares of the company’s stock, valued at approximately $1,186,500.21. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Corporate insiders own 4.60% of the company’s stock.

Addus HomeCare Stock Down 1.6 %

Shares of NASDAQ:ADUS opened at $116.95 on Wednesday. The firm has a market capitalization of $1.91 billion, a P/E ratio of 29.02, a P/E/G ratio of 2.27 and a beta of 1.01. The company has a debt-to-equity ratio of 0.14, a quick ratio of 1.35 and a current ratio of 1.35. The stock has a 50 day moving average price of $112.92 and a 200-day moving average price of $101.06. Addus HomeCare Co. has a 52-week low of $78.35 and a 52-week high of $120.53.

Addus HomeCare (NASDAQ:ADUSGet Free Report) last posted its quarterly earnings data on Monday, May 6th. The company reported $1.21 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.97 by $0.24. The business had revenue of $280.70 million during the quarter, compared to the consensus estimate of $279.49 million. Addus HomeCare had a return on equity of 10.03% and a net margin of 6.04%. The firm’s quarterly revenue was up 11.6% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.84 earnings per share. As a group, equities research analysts anticipate that Addus HomeCare Co. will post 4.36 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of analysts have recently weighed in on ADUS shares. Macquarie assumed coverage on Addus HomeCare in a research note on Friday, June 28th. They set an “outperform” rating and a $136.00 price objective for the company. Barclays lowered shares of Addus HomeCare from an “equal weight” rating to an “underweight” rating and set a $83.00 price target on the stock. in a report on Tuesday, April 23rd. StockNews.com downgraded shares of Addus HomeCare from a “strong-buy” rating to a “buy” rating in a research note on Sunday. TD Cowen raised their target price on Addus HomeCare from $119.00 to $128.00 and gave the stock a “buy” rating in a research note on Tuesday, June 18th. Finally, Stephens upped their price target on Addus HomeCare from $120.00 to $128.00 and gave the company an “overweight” rating in a research report on Friday, May 31st. One equities research analyst has rated the stock with a sell rating and nine have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $116.25.

Get Our Latest Stock Report on ADUS

Addus HomeCare Profile

(Free Report)

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.

Further Reading

Want to see what other hedge funds are holding ADUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Addus HomeCare Co. (NASDAQ:ADUSFree Report).

Institutional Ownership by Quarter for Addus HomeCare (NASDAQ:ADUS)

Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.